Biotech Values

[oc631]

There are still more experts in AD who believe AB is relevant than there are experts who believe it isn’t.

Right. My sister works for the Taub Institute in NYC. They have been strong supporters of the amyloid hypothesis



http://www.cumc.columbia.edu/dept/taub/index.html



I asked her to pose McBio's question on Verubecestat differentiation to one of the lead clinical experts in the field. With his permission, I'll post his name and/or response after the holidays.

I try to respect the lines between academia and investment. It's hard to ask questions about BACE inhibitors without sounding condescending, considering the disappointment and failure rate. Being a supporter and large shareholder in LGND, it would also be prudent for me to ask this question to the team that designed the molecule. Thanks for the homework McBio. Perhaps I should go back to semi-retirement and lurking...